Identifying which patients are infected is key! 🔑
➡️Clinicians do a poor job at identifying infections in patients.
➡️Objective vital signs / labs are slightly better but have their own issues.
➡️detecting/predicting infection or organ dysfunction
➡️heterogeneity of sepsis
➡️# at risk is much much higher than those who progress to organ dysfunction or shock
DATA!!
The Rapid Analysis of Threat Exposure (RATE) owned by the Department of Defense, claims to predict infection 48hr before clinical suspicion better than 85% accuracy....
no public papers/data
➡️CITRIS-ALI no difference in SOFA score or biomarkers (primary outcomes), secondary analysis of mortality was significant (?? meaningful)
➡️VITAMINS with no difference in mortality
➡️ACT reduced SOFA score
ViCTAS trial currently under peer review!!! Looking forward to those results. Hope that this will guide further treatment decisions regarding triple therapy of vitamin C, steroids, and thiamine.
PETALS CLOVER Trial ongoing
(Crystalloid Liberal Or Vasopressors Early in Resuscitation in Sepsis)
aims to enroll >2300 patients
primary outcome 90 day inpatient mortality
And comparison of COVID-19 VTE and historical ICU co-horts. Thrombosis in COVID higher in well matched ARDS patients and also higher than in patients with flu. @accpchest#CHEST2020#CHESTCritCare
At 12 months only 44% of ICU survivors are PICS-free, being cognitive a significative part of the post-ICU impairment. With more ICU survivors, we will likely be seeing more PICS. #CHEST2020#CHESTCritCare
The lack of visitors in the COVID-19 era, will likely contribute to higher number of survivors with PICS #CHEST2020#CHESTCritCare
First up: Props to #CHEST2020 learning partners for that amazing wait music. Ne'er been a fan of wait music. But this is ... well .. peppy. Am in the mood to learn about #AirwayManagement!
.@J_Mendelson_MD: HFNC and proning in severe hypoxic resp failure:
- Can reduce dead space ventilation, assist with WOB, improved resp mechanics
- Pre-COVID data: Can be successful in potentially preventing invasive ventilation vs NIV and low flow O2
Here are the competitors:
Dr. Bowton: The Real Deal Tarheel @KristinBurkart3: The Beat of the Northeast @SMHollenberg: The Heartless Cardiologist @ammo_uw: Dr. "Who Can Ask for Anything" Morris
Role of glucocorticoids in CAP:
Dr. Bowton: No mortality benefit @SMHollenberg: Loses points 4 trying to get points. "It's a toss-up" @ammo_uw: "Depends": How do you define severe" They help for severe! @KristinBurkart3: Do the "boys" never find indication? ... burn!
@mnarasimhan highlights that as we know more about the natural course of COVID-19 we have seen that #PPE works! Also, that we should try non-invasive ventilation in COVID-19 patients as long as we have appropriate PPE #CHEST2020#CHESTCritCare
@RMavesMd highlighted that several countries in the South Hemisphere didn't have as much flu this season as in previous years, and hopefully we will see the same phenomenon in the US now that flu season is coming #CHEST2020#CHESTCritCare